FDA Expects Draft Document On Post-Approval Study Design By September
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes to complete a draft scientific document on how to design post-approval studies for medical devices by September, according to Danica Marinac-Dabic, director of the Division of Epidemiology within CDRH's Office of Surveillance and Biometrics
You may also be interested in...
Post-Approval Study Data Can Be Obtained From Registries, FDA Says
FDA is urging manufacturers to tap into data from existing device registries to help fulfill post-approval study requirements in a practical way
Post-Approval Study Data Can Be Obtained From Registries, FDA Says
FDA is urging manufacturers to tap into data from existing device registries to help fulfill post-approval study requirements in a practical way
FDA May Impose More "522" Studies As Post-Approval Enforcement Tool
FDA says it will more frequently use its authority to mandate so-called Section 522 post-market studies when companies fail to meet their original post-approval study requirements - and this time, the idea might actually stick